Board approves formulary recommendations; actuary reports reserves remain healthy

Staff presented the formulary recommendations that were approved by the advisory commissions for August, September and October and recommended the board adopt the Navis signature select recommendations where applicable. The board moved to approve the formulary recommendations; the motion was seconded and approved by voice vote (no roll‑call counts provided in the transcript).

Separately, staff provided the latest Milliman actuary report on plan reserves. Presenters said reserves for ASE and PSE are projected to remain at a healthy balance through the end of 2023 and that financial projections remain on track with the five‑year cost‑sharing objectives. Board members asked whether the favorable results are expected to continue; staff affirmed the plans are on a good path for future financial stability.

What’s next: The transcript shows no further action beyond approval of the recommendations and the actuary update; staff will continue routine monitoring and reporting to the board.